Skip to content
2000
Volume 21, Issue 23
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The need to overcome ever-increasing cases of antifungal resistance and circumvent side effects and drug interactions related to currently available drugs has impelled the demand to expedite the drug discovery and the development of novel antifungals. 1,4-disubstituted 1,2,3-triazole has gained tremendous interest in the last two decades mainly because of its ease of synthesis via copper( I)-catalyzed azide-alkyne cycloaddition (CuAAC) and its broad spectrum of chemotherapeutic potential. 1,2,3-Triazole is an excellent pharmacophore that has been used as a bioisostere for obtaining libraries of new medicinally important scaffolds. The present review focuses on the recent advances (2016-2021) in 1,2,3-triazole derivatives obtained by CuAAC as potential antifungal agents that may facilitate the triazole-based antifungal development process.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026621666210913122828
2021-09-01
2025-06-21
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026621666210913122828
Loading

  • Article Type:
    Review Article
Keyword(s): 1; 2; 3-triazole; Antifungal activity; Click reaction; CuAAC; fungal infections; Triazole hybrids
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test